DanielAnthonySweeneyMD
Internal Medicine • San Diego, CACritical Care Medicine, Infectious Disease
Physician
Dr. Sweeney is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 W Arbor Dr
San Diego, CA 92103Phone+1 858-657-7000Fax+1 301-581-0077- Is this information wrong?
Summary
- Dr. Daniel Sweeney is a pulmonologist in San Diego, CA and is affiliated with UC San Diego Medical Center – Hillcrest. He received his medical degree from University of Texas Southwestern Medical School and has been in practice 16 years. He specializes in critical care medicine and infectious disease and is experienced in critical care, infectious diseases, neurocritical care, point-of-care ultrasound.
Education & Training
National Institutes of Health Clinical CenterFellowship, Critical Care Medicine (Internal Medicine), 2004 - 2008
Johns Hopkins UniversityFellowship, Infectious Disease, 2005 - 2007
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2001 - 2004
University of Texas Southwestern Medical SchoolClass of 2001
Certifications & Licensure
CA State Medical License 2010 - 2025
MD State Medical License 2004 - 2011
DC State Medical License 2008 - 2010- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Challenges for a broad international implementation of the current severe community-acquired pneumonia guidelines.Jorge I F Salluh, Pedro Póvoa, Abi Beane, Andre Kalil, Cornelius Sendagire, Daniel A Sweeney, David Pilcher, Eva Polverino, Evelina Tacconelli, Elisa Estenssoro, Jean-...> ;Intensive Care Medicine. 2024 Apr 1
- 1 citationsChoosing immunomodulating therapies for the treatment of COVID-19: recommendations based on placebo-controlled trial evidence.Lobo, S., Póvoa, P., Sweeney, D., Kalil, A.> ;Clinical Microbiology and Infection. 2024 Jan 3
- 1 citationsImproving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures: A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position Paper.Chanu Rhee, Jeffrey R Strich, Kathleen Chiotos, David C Classen, Sara E Cosgrove, Ron Greeno, Emily L Heil, Sameer S Kadri, Andre C Kalil, David N Gilbert, Henry Masur...> ;Clinical Infectious Diseases. 2024 Mar 20
- Join now to see all
Journal Articles
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19Victor Tapson, Daniel A Sweeney, Richard A Mularski, Alpesh N Amin, Joanne Billings, Marie-Carmelle Elie, The New England Journal of Medicine
- Remdesivir for the Treatment of Covid-19 — Final ReportAneesh K Mehta, Barry S Zingman, Andre C Kalil, Helen Y Chu, Robert W Finberg, Kerry Dierberg, Victor Tapson, Lanny Hsieh, Thomas F Patterson, Daniel A Sweeney, Willia..., The New England Journal of Medicine
Press Mentions
Coronavirus Is Detectable Next to the Beds of COVID-19 Patients – but Surface Transmission Is RareJune 10th, 2021
The Microbiome of the Critically Ill PatientSeptember 23rd, 2020
Hospital Affiliations
UC San Diego Medical Center - HillcrestSan Diego, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
